Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Zuckermann, E. Garcia, Ivan Luque, J. Christopher-Hennings, A. Doster, M. Brito, F. Osorio (2007)
Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge.Veterinary microbiology, 123 1-3
(1283)
The Immune responses to PRRSV VLP vaccine
Dong‐Hun Lee, Jae-Keun Park, Yu‐Na Lee, J. Song, Sang-Moo Kang, Joong-Bok Lee, Seung-Yong Park, I. Choi, Chang-Seon Song (2011)
H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals.Vaccine, 29 23
P. Lenz, P. Day, Y. Pang, S. Frye, Peter Jensen, D. Lowy, J. Schiller (2001)
Papillomavirus-Like Particles Induce Acute Activation of Dendritic Cells1The Journal of Immunology, 166
E. Kurstak, P. Tijssen, C. Kurstak, R. Morisset (1986)
Enzyme immunoassays and related procedures in diagnostic medical virology.Bulletin of the World Health Organization, 64 3
Tea Kirkegaard, A. Wheatley, J. Melchjorsen, S. Bahrami, F. Pedersen, R. Center, D. Purcell, L. Ostergaard, M. Duch, M. Tolstrup (2011)
Induction of humoral and cellular immune responses against the HIV-1 envelope protein using γ-retroviral virus-like particlesVirology Journal, 8
Haifeng Song, V. Wittman, Anthony Byers, Tenekua Tapia, Bin Zhou, W. Warren, Penny Heaton, Kevin Connolly (2010)
In vitro stimulation of human influenza-specific CD8+ T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine.Vaccine, 28 34
Peter Delputte, N. Vanderheijden, Hans Nauwynck, M. Pensaert (2002)
Involvement of the Matrix Protein in Attachment of Porcine Reproductive and Respiratory Syndrome Virus to a Heparinlike Receptor on Porcine Alveolar MacrophagesJournal of Virology, 76
R. Haupt, H. Sings (2011)
The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine gardasil.The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 49 5
R. Schirmbeck, W. Böhm, J. Reimann (1996)
Virus-Like Particles Induce MHC Class I-Restricted T-Cell ResponsesIntervirology, 39
Emilie Weiland, M. Wieczorek-Krohmer, D. Kohl, K. Conzelmann, F. Weiland (1999)
Monoclonal antibodies to the GP5 of porcine reproductive and respiratory syndrome virus are more effective in virus neutralization than monoclonal antibodies to the GP4.Veterinary microbiology, 66 3
E. Neumann, J. Kliebenstein, C. Johnson, J. Mabry, E. Bush, A. Seitzinger, A. Green, J. Zimmerman (2005)
Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States.Journal of the American Veterinary Medical Association, 227 3
H. Mardassi, Bernard Massie, Serge Dea (1996)
Intracellular synthesis, processing, and transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and respiratory syndrome virus.Virology, 221 1
R. Bright, Donald Carter, S. Daniluk, F. Toapanta, A. Ahmad, Victor Gavrilov, M. Massare, P. Pushko, N. Mytle, T. Rowe, Gale Smith, T. Ross (2007)
Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.Vaccine, 25 19
G. Labarque, K. Reeth, Hans Nauwynck, C. Drexler, S. Gucht, M. Pensaert (2004)
Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy.Vaccine, 22 31-32
P. Pegu, R. Helmus, Phalguni Gupta, P. Tarwater, Lori Caruso, Chengli Shen, T. Ross, Yue Chen (2011)
Induction of strong anti-HIV cellular immunity by a combination of Clostridium perfringens expressing HIV gag and virus like particles.Current HIV research, 9 8
Mi-Yuan Chia, S. Hsiao, H. Chan, Y. Do, Pung-Ling Huang, Hui-Wen Chang, Y. Tsai, Chun-Ming Lin, V. Pang, C. Jeng (2010)
The immunogenicity of DNA constructs co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus conjugated by GPGP linker in pigs.Veterinary microbiology, 146 3-4
R. Kirnbauer, F. Booy, N. Cheng, D. Lowy, J. Schiller (1992)
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.Proceedings of the National Academy of Sciences of the United States of America, 89 24
H. Nielsen, M. Oleksiewicz, R. Forsberg, Tomasz Stadejek, A. Bøtner, T. Storgaard (2001)
Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations.The Journal of general virology, 82 Pt 6
G. Wensvoort, C. Terpstra, J. Pol, E. Laak, M. Bloemraad, E. Kluyver, C. Kragten, L. Buiten, A. Besten, F. Wagenaar, J. Broekhuijsen, P. Moonen, T. Zetstra, E. Boer, H. Tibben, M. Jong, P. Veld, G. Greenland, J. Gennep, M. Voets, J. Verheijden, J. Braamskamp (1991)
Mystery swine disease in The Netherlands: the isolation of Lelystad virus.The Veterinary quarterly, 13 3
P. Martelli, S. Gozio, L. Ferrari, S. Rosina, E. Angelis, C. Quintavalla, E. Bottarelli, P. Borghetti (2009)
Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.Vaccine, 27 28
Safary Assad, André Francis (1999)
Over a decade of experience with a yeast recombinant hepatitis B vaccine.Vaccine, 18 1-2
Y. Tsunetsugu-Yokota, Y. Morikawa, Maya Isogai, A. Kawana-Tachikawa, T. Odawara, Tetsuya Nakamura, F. Grassi, B. Autran, A. Iwamoto (2003)
Yeast-Derived Human Immunodeficiency Virus Type 1 p55gag Virus-Like Particles Activate Dendritic Cells (DCs) and Induce Perforin Expression in Gag-Specific CD8+ T Cells by Cross-Presentation of DCsJournal of Virology, 77
R. Bastos, O. Dellagostin, R. Barletta, A. Doster, E. Nelson, F. Osorio (2002)
Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus.Vaccine, 21 1-2
Shengpin Wang, L. Fang, H. Fan, Yunbo Jiang, Yongfei Pan, Rui Luo, Q. Zhao, Huanchun Chen, Shaobo Xiao (2007)
Construction and immunogenicity of pseudotype baculovirus expressing GP5 and M protein of porcine reproductive and respiratory syndrome virus.Vaccine, 25 49
J. Meulenberg, A. Besten, E. Kluyver, A. Nieuwstadt, G. Wensvoort, R. Moormann (1997)
Molecular characterization of Lelystad virusVeterinary Microbiology, 55
C. Terpstra, G. Wensvoort, J. Pol (1991)
Experimental reproduction of porcine epidemic abortion and respiratory syndrome (mystery swine disease) by infection with Lelystad virus: Koch's postulates fulfilled.The Veterinary quarterly, 13 3
A. García-Piñeres, A. Hildesheim, L. Dodd, T. Kemp, Marcus Williams, Clayton Harro, D. Lowy, J. Schiller, L. Pinto (2007)
Cytokine and Chemokine Profiles following Vaccination with Human Papillomavirus Type 16 L1 Virus-Like ParticlesClinical and Vaccine Immunology, 14
R. Allende, R. Allende, T. Lewis, Zhiqiang Lu, D. Rock, G. Kutish, A. Ali, A. Doster, F. Osorio (1999)
North American and European porcine reproductive and respiratory syndrome viruses differ in non-structural protein coding regions.The Journal of general virology, 80 ( Pt 2)
R. Schirmbeck, W. Böhm, J. Reimann (1996)
Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen.Intervirology, 39 1-2
Mariela Scortti, C. Prieto, E. Álvarez, I. Simarro, José Castro (2007)
Failure of an inactivated vaccine against porcine reproductive and respiratory syndrome to protect gilts against a heterologous challenge with prrsvVeterinary Record, 161
Osvaldo Lopez, Osvaldo Lopez, M. Oliveira, E. Garcia, Byung Kwon, Alan Doster, F. Osorio (2007)
Protection against Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Infection through Passive Transfer of PRRSV-Neutralizing Antibodies Is Dose DependentClinical and Vaccine Immunology, 14
R. Wagner, H. Fließbach, G. Wanner, M. Motz, M. Niedrig, G. Deby, A. Brunn, H. Wolf (2005)
Studies on processing, particle formation, and immunogenicity of the HIV-1gag gene product: a possible component of a HIV vaccineArchives of Virology, 127
X. Meng (2000)
Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine developmentVeterinary Microbiology, 74
Qi-sheng Zheng, De-sheng Chen, Peng Li, Zhi-xiang Bi, Ruibing Cao, Bin Zhou, Pu-yan Chen (2007)
Co-expressing GP5 and M proteins under different promoters in recombinant modified vaccinia virus ankara (rMVA)-based vaccine vector enhanced the humoral and cellular immune responses of porcine reproductive and respiratory syndrome virus (PRRSV)Virus Genes, 35
J. Meulenberg, M. Hulst, E. Meijer, P. Moonen, A. Besten, E. Kluyver, G. Wensvoort, R. Moormann (1993)
Lelystad Virus, the Causative Agent of Porcine Epidemic Abortion and Respiratory Syndrome (PEARS), Is Related to LDV and EAVVirology, 192
Roeland Wieringa, A. Vries, J. Meulen, G. Godeke, J. Onderwater, H. Tol, H. Koerten, A. Mommaas, E. Snijder, P. Rottier (2004)
Structural Protein Requirements in Equine Arteritis Virus AssemblyJournal of Virology, 78
T. Sasagawa, P. Pushko, G. Steers, S. Gschmeissner, M. Hajibagheri, J. Finch, L. Crawford, M. Tommasino (1995)
Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe.Virology, 206 1
P. Gonin, B. Pirzadeh, C. Gagnon, S. Dea (1999)
Seroneutralization of Porcine Reproductive and Respiratory Syndrome Virus Correlates with Antibody Response to the GP5 Major Envelope GlycoproteinJournal of Veterinary Diagnostic Investigation, 11
C. Prieto, E. Álvarez, F. Martínez-Lobo, I. Simarro, J. Castro (2008)
Similarity of European porcine reproductive and respiratory syndrome virus strains to vaccine strain is not necessarily predictive of the degree of protective immunity conferred.Veterinary journal, 175 3
R. Molina, R. Molina, S.-H. Cha, S.-H. Cha, W. Chittick, W. Chittick, S. Lawson, S. Lawson, M. Murtaugh, M. Murtaugh, Eric Nelson, Eric Nelson, J. Christopher-Hennings, J. Christopher-Hennings, Kyoung-Jin Yoon, Kyoung-Jin Yoon, Richard Evans, Richard Evans, Raymond Rowland, Raymond Rowland, Jeff Zimmerman, Jeff Zimmerman (2008)
Immune response against porcine reproductive and respiratory syndrome virus during acute and chronic infection.Veterinary immunology and immunopathology, 126 3-4
Virus Genes
B. Pirzadeh, Serge Dea (1998)
Immune response in pigs vaccinated with plasmid DNA encoding ORF5 of porcine reproductive and respiratory syndrome virus.The Journal of general virology, 79 ( Pt 5)
W. Breedam, H. Gorp, Jiquan Zhang, P. Crocker, P. Delputte, H. Nauwynck (2010)
The M/GP5 Glycoprotein Complex of Porcine Reproductive and Respiratory Syndrome Virus Binds the Sialoadhesin Receptor in a Sialic Acid-Dependent MannerPLoS Pathogens, 6
M. Murtaugh, M. Genzow (2011)
Immunological solutions for treatment and prevention of porcine reproductive and respiratory syndrome (PRRS).Vaccine, 29 46
Kiwon Han, H. Seo, J. Shin, Y. Oh, I. Kang, Changhoon Park, C. Chae (2011)
Effect of the Modified Live Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Vaccine on European and North American PRRSV Shedding in Semen from Infected BoarsClinical and Vaccine Immunology, 18
T. Vicente, A. Roldão, C. Peixoto, M. Carrondo, P. Alves (2011)
Large-scale production and purification of VLP-based vaccinesJournal of Invertebrate Pathology, 107
C. Ludwig, R. Wagner (2007)
Virus-like particles—universal molecular toolboxesCurrent Opinion in Biotechnology, 18
J. Collins, D. Benfield, W. Christianson, L. Harris, J. Hennings, D. Shaw, S. Goyal, S. McCullough, R. Morrison, H. Joo, D. Gorcyca, D. Chladek (1992)
Isolation of Swine Infertility and Respiratory Syndrome Virus (Isolate ATCC VR-2332) in North America and Experimental Reproduction of the Disease in Gnotobiotic PigsJournal of Veterinary Diagnostic Investigation, 4
K. Conzelmann, N. Visser, P. Woensel, H. Thiel (1993)
Molecular Characterization of Porcine Reproductive and Respiratory Syndrome Virus, a Member of the Arterivirus GroupVirology, 193
Wenming Jiang, P. Jiang, Yufeng Li, Jingyuan Tang, XianWei Wang, Suping Ma (2006)
Recombinant adenovirus expressing GP5 and M fusion proteins of porcine reproductive and respiratory syndrome virus induce both humoral and cell-mediated immune responses in mice.Veterinary immunology and immunopathology, 113 1-2
E. Wissink, M. Kroese, H. Wijk, F. Rijsewijk, J. Meulenberg, P. Rottier (2005)
Envelope Protein Requirements for the Assembly of Infectious Virions of Porcine Reproductive and Respiratory Syndrome VirusJournal of Virology, 79
K. Madsen, C. Hansen, E. Madsen, B. Strandbygaard, A. Bøtner, K. Sorensen (1998)
Sequence analysis of porcine reproductive and respiratory syndrome virus of the American type collected from Danish swine herdsArchives of Virology, 143
D. Linhares, J. Cano, T. Wetzell, J. Nerem, M. Torremorell, S. Dee (2012)
Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs.Vaccine, 30 2
A. Brun, J. Bárcena, E. Blanco, B. Borrego, D. Dory, J. Escribano, G. Gall-Reculé, J. Ortego, L. Dixon (2011)
Current strategies for subunit and genetic viral veterinary vaccine development.Virus research, 157 1
W. Mcaleer, E. Buynak, R. Maigetter, D. Wampler, W. Miller, M. Hilleman (1984)
Human hepatitis B vaccine from recombinant yeastNature, 307
Wai-Hong Wu, Ying Fang, Rachel Farwell, M. Steffen-Bien, R. Rowland, J. Christopher-Hennings, E. Nelson (2001)
A 10-kDa structural protein of porcine reproductive and respiratory syndrome virus encoded by ORF2b.Virology, 287 1
Yunbo Jiang, Shaobo Xiao, L. Fang, Xiaolan Yu, Yunfeng Song, Chuanshuang Niu, Huanchun Chen (2006)
DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity.Vaccine, 24 15
C. Nelsen, M. Murtaugh, K. Faaberg (1999)
Porcine Reproductive and Respiratory Syndrome Virus Comparison: Divergent Evolution on Two ContinentsJournal of Virology, 73
C. Johnson, Theodor Griggs, J. Gnanandarajah, M. Murtaugh (2011)
Novel structural protein in porcine reproductive and respiratory syndrome virus encoded by an alternative ORF5 present in all arterivirusesThe Journal of General Virology, 92
V. Dwivedi, C. Manickam, R. Patterson, Katie Dodson, M. Murtaugh, J. Torrelles, L. Schlesinger, G. Renukaradhya (2011)
Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvantVaccine, 29
Hyunil Kim, H. Kim, Jung Jung, Yoon-jung Choi, Jiho Kim, Chang Um, S. Hyun, Sungho Shin, Byeongchun Lee, G. Jang, B. Kang, H. Moon, D. Song (2011)
The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methodsVirology Journal, 8
A. Roldão, M. Mellado, L. Castilho, M. Carrondo, P. Alves (2010)
Virus-like particles in vaccine developmentExpert Review of Vaccines, 9
Porcine reproductive and respiratory syndrome virus (PRRSV) induces reproductive failure in sows and respiratory problems in pigs of all ages. Live attenuated and inactivated vaccines are used on swine farms to control PRRSV. However, their protective efficacy against field strains of PRRSV remains questionable. New vaccines have been developed to improve the efficacy of these traditional vaccines. In this study, virus-like particles (VLPs) composed of the GP5 and M proteins of PRRSV were developed, and the capacity of the VLPs to elicit antigen-specific immunity was evaluated. Serum antibody titers and production of cytokines were measured in BALB/C mice immunized intramuscularly three times with different doses (0.5, 1.0, 2.0, and 4.0 μg) of the VLP vaccine. A commercial vaccine consisting of inactivated PRRSV and phosphate-buffered saline (PBS) were used as positive and negative controls, respectively. IgG titers to GP5 were significantly higher in all groups of mice vaccinated with the VLPs than in control mice. Neutralizing antibodies were only detected in mice vaccinated with 2.0 and 4.0 μg of the VLPs. Cytokine levels were determined in cell culture supernatants after in vitro stimulation of splenocytes with the VLPs for 3 days. Mice immunized with 4.0 μg of the VLPs produced a significantly higher amount of interferon-gamma (IFN-γ) than mice immunized with the commercial inactivated PRRSV vaccine and PBS. In contrast, immunization with the commercial vaccine induced higher production of IL-4 and IL-10 in mice than mice vaccinated with VLPs. These data together demonstrate the capacity of VLPs to induce both neutralizing antibodies and IFN-γ in immunized mice. The VLP vaccine developed in this study could serve as a platform for the generation of improved VLP vaccines to control PRRSV.
Archives of Virology – Springer Journals
Published: Jun 1, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.